Smoke-free homes for residents of subsidized housing
A smoke-free home intervention in federally subsidized housing
This project helps adults living in federally subsidized housing, especially Black, Latino, and Asian households with limited English, adopt smoke-free home rules and access quitting support.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11325271 on NIH RePORTER |
What this research studies
You would be invited to work with housing staff and study staff to encourage voluntary smoke-free home rules in your apartment or building. The team will offer culturally and linguistically tailored information and smoking-cessation resources, and help connect residents to quit-smoking services. They will track whether households adopt smoke-free rules, changes in smoking behavior, and reductions in secondhand smoke exposure over time. The program builds on earlier pilot work and is delivered in partnership with subsidized housing communities.
Who could benefit from this research
Good fit: Adults (21+) living in federally subsidized housing, particularly Black/African American, Hispanic/Latino, and Asian residents or households with limited English proficiency who smoke or are exposed to household smoking.
Not a fit: People who do not live in subsidized housing or who are unwilling to change home smoking rules or use offered cessation services are unlikely to benefit.
Why it matters
Potential benefit: If successful, this could lower residents' exposure to secondhand smoke and increase quitting, which may reduce tobacco-related illness and deaths in these communities.
How similar studies have performed: Earlier pilot work by the team showed feasibility and early success increasing voluntary smoke-free home adoption, though broader implementation evidence remains limited.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Vijayaraghavan, Maya — University of California, San Francisco
- Study coordinator: Vijayaraghavan, Maya
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.